MORN— AI Stock Forecast & Price Targets
Published 7/9/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live MORN price forecast →
Morningstar is a high-quality data/analytics franchise (30.7% ROE, 62% gross margin, $453M FCF) that has been violently re-rated to -46% off 52W highs and -24% YTD, now trading at 12.3x forward EPS with PEG 0.70. The July 29 earnings print is a binary catalyst that dominates near-term risk/reward; balance sheet leverage (D/E 1.87, Current Ratio 1.00) and a fresh analyst downgrade temper conviction, but the fundamental setup supports patient accumulation into weakness.
1-4 week view: HOLD/small ACCUMULATE only. The July 29 earnings print (~20 days out) is a binary catalyst — do NOT size a swing bet into it. Any trim/add should be pre-earnings and position-scaled. Levels: buy zone $155-$162 (near recent capitulation base and the $157.67 anchor); reclaim of $173 opens $180-$185; invalidation on a daily close below $150 (retests $141 low). Ex-div on July 10 is a non-event (~$0.50 step). Explicit earnings stance: enter with reduced size, expect an IV crush and a 5-10% gap in either direction; the key print items are operating margin trajectory (must confirm the 24.2% Q1 level or better) and management's clarification of the $880M incremental debt use.
1-6 month view: ACCUMULATE. Base case: a merely in-line print with reaffirmed guidance re-rates the stock toward $185-$195 as forward P/E normalizes from 12.3x back toward mid-teens on a $13.45 forward EPS base. Catalysts: earnings on 7/29, PitchBook 'Time to Exit' adoption signals, any capital allocation disclosure (buyback or M&A) that clarifies the debt raise. What would change my mind: an operating margin regression below 22%, revenue growth decelerating below 6%, or a further analyst downgrade cluster. Expected return range in base case: +12% to +20% over 6 months; downside -15% if earnings disappoint and stock retests $141.
1-3 year view: constructive. Terminal thesis rests on Morningstar's dominance in independent investment data plus PitchBook's continued expansion into private markets (VC, PE, credit, M&A) becoming a structural growth engine layered on top of a maturing core. Multi-year drivers: (1) PitchBook attach/upsell (Time to Exit is a concrete example), (2) Morningstar DBRS credit ratings growth, (3) Indexes/Sustainalytics recurring revenue, (4) operating leverage from platform consolidation lifting margins toward mid-to-high 20s. Biggest structural risk: generative AI disintermediating research/ratings workflows — the very thing Morningstar sells. Secondary risk is that management pursues expensive M&A with the levered balance sheet and destroys ROIC (currently 14.1%). At 12.3x forward EPS with 30%+ ROE, the setup rewards patient holders if the franchise proves AI-resilient.
The core franchise remains demonstrably intact: Q1'26 revenue of $644.8M grew ~6.6% YoY with operating margin expanding to 24.2% (from ~20.7% in Q3'25 and 20.7% in Q2'25), and net margin at 16.6%. Gross margin held at 62.9% and TTM ROE at 30.7% with ROIC of 14.1% — hallmarks of a subscription-heavy compounder. FCF generation is durable at $453M TTM (P/FCF 14.4x). The concern is the balance sheet: total debt jumped from $1.04B (Q3'25) to $1.91B (Q1'26), while equity fell from $1.51B to $1.02B, pushing D/E to 1.87 and dropping the current ratio to 1.00 — capital allocation of that ~$880M incremental debt is the single most important unknown. On valuation, forward P/E of 12.3x with PEG 0.70 is inexpensive for a 30%+ ROE franchise; EV/EBITDA of 10.1x is well below historical norms. TTM EPS $9.81 is compounding (EPS Q/Q +49.6%, EPS Y/Y TTM +10.1%), and analyst consensus PT $227 implies material re-rating if the July 29 print confirms margin trajectory.
Across timeframes the picture is a stabilization attempt inside a broken longer-term trend. On the 1wk chart price cratered from ~$350 into a $141 low and now sits at ~$166 — a partial mean-reversion but still deep in a downtrend, with the forecast band pointing to $279 as a distant magnet. The 1d/4h charts show a base forming in the $150s–$170s after the July capitulation, with forecast overlays projecting drift toward $205-$212 into September/October. On the 1h, the actual line at $157.67 has already rebounded to ~$166 with forecast pointing at $176.91 — but the model's realized 1d directional accuracy is only 42% vs 52% naive (BEATEN by naive), so the short-term overlay is unreliable and should be heavily discounted. Key levels: support at $141 (52W low) and $150-$155 shelf; resistance at $173 (technical reclaim level per prior work), then $180-$185. SMA200 is -14.7% overhead, SMA50 -3.9%, SMA20 +0.4% — a bottoming setup but not yet a confirmed uptrend. RSI 48.7 is neutral. Perf Week +5.8% shows a bounce; -3.5% today reflects the heavy near-earnings jitter and 9.72% short float.
Signal: (1) PitchBook launched 'Time to Exit,' an ML-based predictive tool forecasting VC exit timing — evidence the PitchBook growth engine keeps deepening private-market moat, a key structural driver. (2) UBS maintained Buy but cut price target from $280 to $260 — still constructive but reflects the sell-side rating drift flagged in fundamental-change signals (analyst rating drift 1.00 → 1.67). (3) Morningstar published a bearish warning on AI/memory chip stocks — reinforces the brand's independent research franchise, no direct P&L impact. (4) SEC 8-K filings on 6/25 (Reg FD/guidance-related) and 6/18 (other material event) warrant attention as pre-earnings disclosures. Noise: various syndication of the same PitchBook and AI-chip commentary. Retail sentiment is bullish but thin (100% bullish of 3 tagged, 15 messages); Q2 Street EPS consensus is $2.82.
- PitchBook 'Time to Exit' (announced 7/9/2026) — ML-based prediction of VC-backed exit timing, extends analytics moat into a novel forecasting workflow
- Operating margin expansion trajectory: 20.7% Q3'25 → 21.4% Q4'25 → 24.2% Q1'26; confirmation on 7/29 print supports a re-rating
- Morningstar DBRS credit franchise (CLO daily valuation indexes) expanding into higher-margin ratings analytics
- Enterprise workflow embedding (Microsoft 365 Copilot integration) increases switching costs on Direct/Advisor Workstation
- Morningstar Wealth semiliquid fund research franchise gains relevance as private credit flows shift (per 7/9 CRE Daily coverage)
- July 29 earnings binary — soft margin or guidance triggers a retest of $141 (9%+ downside gap risk)
- Balance sheet stretch: total debt $1.91B vs equity $1.02B (D/E 1.87), current ratio at 1.00 — capital allocation of ~$880M incremental debt is unexplained
- Sell-side conviction drift (analyst rating 1.00 → 1.67 in ~45d; UBS PT cut $280 → $260) signals waning Street enthusiasm
- Elevated crowding: 9.72% short float, 3.98 short ratio — can amplify moves both directions but signals doubt
- Secular risk: generative AI disintermediation of research/ratings services (Morningstar's own bearish AI-chip note ironically underscores the exposure)
- Kronos short-term forecast is model-unreliable in this regime (1d directional accuracy 42% vs 52% naive) — do not lean on the AI overlay for tactical timing
- Insider trans -1.07% and Inst trans -2.80% show mild distribution, not accumulation
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord